CASI Pharma Balance Sheet - Annual (NASDAQ:CASI)

Add to My Stocks
$5.73 $0.01 (0.17%) CASI stock closing price Sep 19, 2018 (Closing)

The financial analysis of a company involves interpreting the income statement, balance sheet and cash flow statements of the company to draw insights like we've done in our CASI Pharma stock analysis. Financial strength can be guaged by performing CASI Pharma stock analysis and by analyzing the balance sheet. A company releases its balance sheet every year along with its annual results. CASI Pharma had a long term debt of $1.49M at the end of 2017. To understand the debt servicing capacity of the company, one needs to look at CASI Pharma operating cash flow and CASI Pharma revenue also. CASI Pharma debt to equity ratio is 0.02.

View latest 10 year balance sheet data to check CASI Pharma financial performance.
show more
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011201020092008
Marketable Securities---------7.54M
Raw Materials----------
Work In Progress----------
Finished Goods----------
Notes Receivable----------
Other Current Assets----------
Total Current Assets
Property Plant & Equipment1.41M------6.29M6.31M6.31M
Accumulated Depreciation-------6.19M6.14M6.04M
Net Property Plant & Equipment
Investment & Advances----------
Other Non-Current Assets----------
Deferred Charges----------
Deposits & Other Assets----------
Total Assets
Notes Payable----------
Accounts Payable2.08M1.06M-----1.35M1.96M3.49M
Current Portion Long-Term Debt--------8.55M7.7M
Current Portion Capital Leases----------
Accrued Expenses---------2.58M
Income Taxes Payable----------
Other Current Liabilities2.22M---------
Total Current Liabilities
Deferred Taxes/Income----------
Convertible Debt----------
Long-Term Debt1.49M1.49M1.46M1.39M-----9.19M
Non-Current Capital Leases----------
Other Long-Term Liabilities-4.12M9.39M9.42M------
Total Liabilities
Minority Interest----------
Preferred Stock------3.35M3.35M3.35M3.35M
Common Stock Net----------
Capital Surplus498.57M470.14M434.09M432.55M421.77M409.37M385.87M384.13M367.99M367.68M
Retained Earnings-452.7M-441.93M-432.47M-425.27M-399.06M-393.33M-378.78M-374.22M-366.12M-357.91M
Treasury Stock8.03M8.03M8.03M8.03M8.03M8.03M8.03M8.03M8.03M8.03M
Other Liabilities----------0.05M
Shareholders Equity38.54M20.78M-6.08M-0.42M14.94M8.23M2.53M5.33M-1.92M5.92M
Total Liabilities & Shareholders Equity45.1M27.71M5.82M11.3M15.5M8.97M3.23M8.03M10.06M28.92M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Looking at CASI Pharma historical stock prices and the current CASI Pharma stock price can tell you how the stock price has moved, whereas the CASI Pharma PE ratio chart shows if its shares are overpriced in comparison to peers. The important things to look for in a balance sheet are:

  • Assets: Anything that the CASI Pharma company owns and is a part of its books. Assets can be of three types: fixed, current and other assets which includes intangibles, advances. Internet companies typically don't have a lot of assets as there is not much investment in say machinery, equipment etc. CASI Pharma had total assets of $45.1M.
  • Liabilities: This item on the balance sheet implies the firm's, in this case CASI Pharma's, legal obligations including loans, accounts payable, deferred revenue, accrued expenses and mortgages. The total liabilities for CASI stock stand at $6.56M.

CASI Pharma Balance Sheet - Key Ratios

Current ratio
Debt to equity ratio
Asset turnover ratio
Receivables turnover